A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087)

Phase 3 Completed 109 enrolled Organon and Co

RandomizedCrossoverDouble-blindTreatment

A study to provide evidence supporting the benefit of Rizatriptan in patients who have an inadequate response to sumatriptan.

Evaluation	Drug	Modality	Dose	Route
Subject	rizatriptan	Unknown	10 mg	Oral
Background	Sumatriptan	Unknown	100 mg	—